Gossamer Bio GOSS
NASDAQ GOSS
$10.71 -0.22 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Cash from Investing Activities (2018 - 2026)

Updated

Gossamer Bio (GOSS) reported Cash from Investing Activities of $42.7 million for Q2 2026, down 3.2% from $44.13 million a year earlier but up 2.6% from the prior quarter.

Analysis

Gossamer Bio (GOSS) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Gossamer Bio's Cash from Investing Activities came in at $174.48 million, up 88.3% year-over-year; for FY2025, it came in at $156.36 million, up 438.7% from FY2024.

  • Cash from Investing Activities has a five-year compound annual growth rate of -6.2% (FY2020 to FY2025).
  • By year, Cash from Investing Activities came in at $29.02 million in FY2024, -$110.97 million in FY2023, -$1.04 million in FY2022 and -$117.43 million in FY2021.
  • Five-year quarterly Cash from Investing Activities spans a low of -$118.26 million in Q3 2023 and a high of $73.16 million in Q4 2025.
  • Year over year, Cash from Investing Activities gained in two of the last four quarters, with growth averaging 14.6%.
  • The high point for year-over-year Cash from Investing Activities in five years was Q1 2024 (growth of 607.1%); the low point was Q4 2021 (a decline of 82.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $41.61 million (Q1 2026), $73.16 million (Q4 2025) and $17.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Gossamer Bio 42.84 Mn -430.56 Mn - 42.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.70 Mn
Mar 31, 2026 41.61 Mn
Dec 31, 2025 73.16 Mn
Sep 30, 2025 17.01 Mn
Jun 30, 2025 44.13 Mn
Mar 31, 2025 22.06 Mn
Dec 31, 2024 53.22 Mn
Sep 30, 2024 -26.75 Mn
Jun 30, 2024 -59.11 Mn
Mar 31, 2024 61.67 Mn
Dec 31, 2023 -14.37 Mn
Sep 30, 2023 -118.26 Mn
Jun 30, 2023 12.94 Mn
Mar 31, 2023 8.72 Mn
Dec 31, 2022 8.46 Mn
Sep 30, 2022 -22.60 Mn
Jun 30, 2022 4.68 Mn
Mar 31, 2022 8.42 Mn
Dec 31, 2021 10.44 Mn
Sep 30, 2021 -89.76 Mn
API Access

Gossamer Bio Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=GOSS&period=max&api_key=YOUR_API_KEY